Growth hormone research
CJC-1295
A synthetic analog of growth hormone–releasing hormone (GHRH) studied for its pulsatile effect on GH release in laboratory settings.
Overview
CJC-1295 is a modified GHRH analog. Two common forms exist: with and without DAC (Drug Affinity Complex), which affects duration in circulation.
Research background
Preclinical and early-stage research. Not an approved therapeutic.
How it works
Binds to GHRH receptors on the pituitary, prompting release of growth hormone in laboratory models.
Common terminology
- GHRH
- Growth Hormone–Releasing Hormone, a natural signaling peptide.
- DAC
- Drug Affinity Complex, a modification that extends half-life.
Storage
Refrigerated. Protect from light after reconstitution.
Mixing example
A reference mix used across the literature — plug it into the calculator to see the exact draw.
- Vial: 2 mg
- BAC water: 2 mL
- Reference dose: 100 mcg
FAQ
What's the difference between CJC-1295 with and without DAC?
DAC greatly extends the peptide's circulating half-life. Non-DAC versions clear more quickly.
Educational purposes only. Nothing on MissnLnk is medical advice, diagnosis, or treatment. Research materials are not for human consumption.